Efficacy of Tafamidis in Transthyretin Amyloid Cardiomyopathy in the ATTR-ACT Trial: Sensitivity Analyses Further Support the Primary Results Maurer, M. S., Schwartz, J. H., Gundapaneni, B., Elliott, P., Merlini, G., Cruz, M., Kristen, A. V., Grogan, M., Witteles, R., Damy, T., Drachman, B. M., Shah, S. J., Hanna, M., Judge, D. P., Gottlieb, S. S., Berk, J. L., Lenihan, D. J., Hoffman, J. E., Hummel, S. L., Velazquez, E. J., Patterson, T. A., Sultan, M. B., Rapezzi, C. CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS. 2018: 813

View details for DOI 10.1016/j.cardfail.2018.11.008

View details for Web of Science ID 000452937400019